Prefilled Saline Flush Syringes segmentation by application reflects the therapeutic contexts that drive demand. In cardiology, flush syringes are used to maintain catheter patency during angiography and electrophysiology procedures; this segment accounts for roughly 30 % of total volume because of high procedure frequency and stringent sterility standards. Critical‑care units rely on rapid line flushing for central venous catheters and arterial lines, contributing about 25 % of market size given the constant bedside usage across intensive‑care beds. Oncology applications involve flushing implantable ports and infusion sets for chemotherapy delivery, representing 20 % of the market as oncology patient numbers rise globally. Diagnostic imaging, particularly computed tomography and magnetic resonance imaging contrast administration, consumes 15 % of syringes, where precise volume control is essential. General surgery, encompassing orthopedic, gastrointestinal and minor outpatient procedures, makes up the remaining 10 % of demand. Collectively, these application segments shape the overall Prefilled Saline Flush Syringes market, with each proportion reflecting procedure prevalence, regulatory requirements, and price sensitivity.
